Rafael Holdings Corp (RFL) Company Value to Net Income

Corporate emblem and logo of Rafael Holdings Corp (RFL)

This visual snapshot of Rafael Holdings, Inc. (RFL) price action demonstrates the performance of a company profiting from real estate holdings and medical developments, where the current ratio is -1.60. The holding company is currently focused on internal capital to support its startups, having temporarily suspended external merger deals. Growth is driven by rental income from Newark offices and the promotion of new oncology drugs.

rafaelholdings.com (RFL) Price to Earnings Ratio: for the period 07/04/2022 - 11/18/2026

Analytical breakdowns for Rafael Holdings, Inc.

- market price and analyst price targets:
Comprehensive company analysis:Rafael Holdings
Flagship merchandise of Rafael Holdings

Effective management of biopharmaceutical assets and real estate at Rafael Holdings, Inc. (RFL) establishes the foundation for the company's business valuation. By analyzing the P/E ratio of Rafael Holdings, Inc. (RFL), an investor sees the result of dividing the market share price by net income, which determines the payback period for investments and allows for the separation of speculative bubbles from the fundamental stability of the investment holding.